Traditional Chinese medicine composition for prevention and treatment of swine toxoplasmosis and preparation method of traditional Chinese medicine composition for prevention and treatment of swine toxoplasmosis

A technology for toxoplasmosis and a composition is applied in the field of traditional Chinese medicine compositions for preventing and treating swine toxoplasmosis and the field of preparation thereof, which can solve the problems of large side effects, high toxicity, increased drug residues and the like, and achieves short course of treatment, difficult recurrence, and no drugs. residual effect

Inactive Publication Date: 2016-06-22
YANTAI MINWANG ELECTROMECHANICAL TECH CO LTD
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Western medicine treats porcine toxoplasmosis, and commonly used mainly adopts sulfonamide drug treatment, and toxicity is big, and side effect is big, and the p

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0051] Embodiment 1 Chinese medicine composition 1

[0052] The embodiment of the present invention provides a kind of traditional Chinese medicine composition that is used for the prevention and treatment of porcine toxoplasmosis, is made of the following raw material medical materials: Artemisia annua 31g, Brucea javanica 5g, honeysuckle 26g, Daqingye 32g, rotten root 13g, 23g of antipodal leaves, 35g of forsythia, 11g of horseshoe root, 18g of oak bark, 9g of phlox, 14g of emblica, 18g of Qingfengteng, 23g of celery, 12g of bamboo yellow, 36g of knotweed, 17g of ground root, 9g of inverted pen, kapok 20g root, 22g flavescens, 7g acacia, 19g geranium, 8g pilchard, 16g mulberry, 12g chuangu root, 22g poplar and 11g cup chrysanthemum.

[0053] The dosage form of the Chinese medicine composition is powder injection, and its preparation method comprises the following steps:

[0054] In the first step, the raw medicinal materials are mixed in proportion, put into an ultrafine pu...

Embodiment 2

[0057] Embodiment 2 Chinese medicine composition 2

[0058] The embodiment of the present invention provides a traditional Chinese medicine composition for preventing and treating swine toxoplasmosis, which is made of the following raw materials in parts by weight: Artemisia annua 28g, Brucea javanica 4g, honeysuckle 34g, Daqingye 37g, root of rotten maiden 17g, 15g of antipodal leaves, 27g of forsythia, 13g of horseshoe root, 15g of oak bark, 10g of old mantle grass, 8g of emblica, 14g of Qingfeng rattan, 20g of celery, 8g of bamboo yellow, 32g of knotweed, 21g of ground root, 13g of inverted pen, kapok 18g root, 25g flavescens, 8g acacia, 15g geranium, 9g pilchard, 18g mulberry, 10g chuangu root, 18g poplar and 12g cup chrysanthemum.

[0059] The dosage form of the Chinese medicine composition is powder, and its preparation method comprises the following steps:

[0060] The first step is to mix the components in the traditional Chinese medicine composition in proportion, pu...

Embodiment 3

[0063] Embodiment 3 Chinese medicine composition 3

[0064] The embodiment of the present invention provides a traditional Chinese medicine composition for preventing and treating swine toxoplasmosis, which is made of the following raw materials in parts by weight: 23g of Artemisia annua, 6g of Brucea javanica, 30g of honeysuckle, 25g of Folium Isatidis, 21g of root of rotten maidenhair, 18g of antipodal leaves, 32g of forsythia, 15g of horseshoe root, 20g of oak bark, 12g of old mantle grass, 10g of emblica, 20g of Qingfeng rattan, 18g of celery, 10g of bamboo yellow, 27g of knotweed, 14g of ground root, 11g of inverted pen, kapok 15g root, 19g flavescens, 9g acacia, 23g geranium, 6g pilchard, 21g mulberry, 8g chuangu root, 15g poplar and 9g cup chrysanthemum.

[0065] The dosage form of the Chinese medicine composition is powder, and its preparation method comprises the following steps:

[0066] The first step is to mix the components in the traditional Chinese medicine com...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Particle sizeaaaaaaaaaa
Login to view more

Abstract

The invention discloses a traditional Chinese medicine composition for prevention and treatment of swine toxoplasmosis and a preparation method of the traditional Chinese medicine composition for prevention and treatment of swine toxoplasmosis. The traditional Chinese medicine composition comprises medicinal materials including Herba Artemisiae Annuae, Fructus Bruceae, Flos Lonicerae, Folium Isatidis, Radix Premnae Microphyllae, Folium Pteracanthi Alati, Fructus Forsythiae, Rhizoma Angiopteridis Magnae, Cortex Querici Mongolicae, Herba Leontopodii Leontopodioidis, Fructus Phyllanthi, Caulis Sinomenii, Herba Apii Graveolentis, Concretio Silicea Bambusae, Rhizoma Polygoni Cuspidati, Herba Melastomatis Dodecandri, Wrightia Pubescens, Radix Bombacis Malabaricae, Radix Sophorae Flavescentis, Fructus Gleditsiae, Cortex et Folium Linderae Communis, Herba Meliloti Suaveolentis, Broussonetia papyrifera, Coix Lachrymajobi, Cortex et Folium Populi Bonati and Cyathocline Purpurea. The traditional Chinese medicine composition has the advantages of swine immunity improvement, high cure rate, less proneness to relapse of toxoplasmosis, pure naturality, freeness of toxic and side effects and low cost.

Description

technical field [0001] The invention relates to the technical field of veterinary medicine, in particular to a traditional Chinese medicine composition for preventing and treating swine toxoplasmosis and a preparation method thereof. Background technique [0002] Swine toxoplasmosis is a protozoan disease caused by Toxoplasma gondii, also known as toxoplasmosis. Toxoplasmosis is a zoonotic disease with a wide variety of hosts and a high infection rate in both humans and animals. According to foreign reports, the average infection rate of the population is 25% to 50%. It is estimated that at least 500 million people in the world are infected with Toxoplasma gondii. When toxoplasmosis breaks out in pigs, the pigs in the whole farm can become ill, and the mortality rate is as high as more than 60%. Toxoplasma gondii infection and toxoplasmosis are widely distributed in my country. According to investigations all over the country, it is confirmed that there are human and live...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/8994A61P33/02
CPCA61K36/282A61K9/0019A61K9/19A61K36/06A61K36/11A61K36/185A61K36/19A61K36/195A61K36/23A61K36/24A61K36/28A61K36/315A61K36/355A61K36/47A61K36/48A61K36/483A61K36/489A61K36/54A61K36/59A61K36/60A61K36/634A61K36/704A61K36/76A61K36/85A61K36/855A61K36/8994A61K2236/15A61K2236/331A61K2236/333A61K2236/39A61K2236/51A61K2236/53A61K2300/00
Inventor 董淑风
Owner YANTAI MINWANG ELECTROMECHANICAL TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap